Media Room

Australian CRO Novotech Expands Asian Footprint Into Southeast Asia Australia’s largest independent contract research organisation, Sydney-based Novotech, is expanding its operations into four new Asian markets and establishing a management hub in Kuala Lumpur, Malaysia. “In keeping with our continued expansion in Asia, we are rolling... Read more

Novotech to Operate in Four More Asian Countries Continuing with its Asian growth plans, Australia-based contract research organization (CRO) Novotech http://www.novotech-cro.com is expanding its operations to include four more Asian countries: Malaysia, Singapore, Thailand and Philippines. Safarian is continuing with Novotech’s Asian expansion... Read more

Novotech expands in Asia with new Malaysian base Novotech says its new “management hub” in Kuala Lumpur, Malaysia will serve as a base for expansion in the booming Asia-Pacific contract research sector. The contract research organisation (CRO), which already has operations in India and Korea, said that, in addition to Malaysia, the facility... Read more

Novotech kicks off Dimebon trial Recruiting has begun for local sites in a Phase III international multi-centre study of the new Pfizer/Medivation Alzheimer’s hope Dimebon (Latrepirdine). CRO Novotech Which is running the CONCERT trial in Australia is looking to recruit patients with mild to moderate Alzheimer’s disease (AD) over... Read more

Interviewing Dr Roger Clarnette, from the McCusker Foundation, who is heading up the clincial trials in Perth for the CONCERT Study. Broadcast: 03/09/2009. Host: Geoff Hutchinson. About this interview: Dr. Roger Clarenette from the McCusker Foundation, who is heading up the clincial trials in Perth for the CONCERT Study, trialing a new Alzheimer’s... Read more

Alzheimer’s Disease Trial Broadcast: 03/09/2009 Host: Geoff Hutchinson About this interview: Dr. Roger Clarenette from the McCusker Foundation, who is heading up the clincial trials in Perth for the CONCERT Study, trialing a new Alzheimer’s drug called dimebon. Dr Roger Clarnette talks about the drugs origins, the results from the... Read more

Biotech Trials plummet The number of clinical trials conducted for Australian biotechnology companies, usually by contract research organisations (CRO), has fallen by about 32 percent in the past year. For a licensed copy [CAL] of this article please email us at: team{at}onlinemediarooms.com Quote #1040 SHARETHIS.addEntry({ title: "BRW",... Read more

Novotech’s success: Instant Update Sydney-based CRO, Novotech, is trumpeting its success despite the tight economic environment, announcing it attracted $22 million worth of new projects in the year to March. The company said it had been awarded 23 new multi-centre phase II and III clinical studies across a variety of therapeutic areas including... Read more

Novotech in Joint Venture with Indian CRO, Focuses on Asian Expansion In keeping with its strategic focus on expanding in Asia, Australia-based contract research organization (CRO) Novotech has entered into a joint venture with ETI Klinical, a CRO based in Bangalore, India, and part of the Karle Group. Novotech already had, and will keep, its... Read more

Novotech Signs Joint Venture with Indian CRO ETI Klinical Novotech, a leading Australia based clinical research company, today announced it had entered into a strategic venture with ETI Klinical Pvt Ltd, part of the Karle Group of companies, a US $600 million Indian multinational. The joint venture designed to service the growing demand for global... Read more

Novotech signs joint venture with Indian CRO ETI Klinical PVT Limited deal to drive more global clinical trials to India Novotech, a leading Australia based clinical research company, today announced it had entered into a strategic venture with ETI Klinical Pvt Ltd, part of the Karle Group of companies, a US $ 600 million Indian multinational. The... Read more

Aussie CRO Novotech Expands Asian Footprint With Indian ETI Joint Venture: An Interview With PharmAsia News The largest independent research organization in Australia, Sydney-based Novotech announced May 6 that it formed a joint venture with Bangalore-based ETI Klinical, which is part of the multinational Karle Group. With operations in Australia,... Read more

Novotech and ETI Ally to Harness Indian Clinical Research Opportunities Australia-based CRO, Novotech, and Indian CRO, ETI Klinical, are teaming up to help meet the growing international demand for clinical research in India. The joint venture aims to cover a wide range of therapeutic areas including oncology, respiratory disorders, infectious... Read more

Biotechs face bloodbath The listed Australian biotechnology sector expects a bloodbath, with industry heavyweights saying the struggles demonstrated by many smaller biotech stocks in February reporting season will leave many unsustainable by the end of the year. For a licensed copy [CAL] of this article please email us at: team{at}onlinemediarooms.com Quote... Read more